Osteoporosis is a skeletal disease characterized by low bone mass and a microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture.
In addition to broken bones, it often leads to constant pain and spinal deformity.
A loss of bone mass can occur over the course of many years without any signs or symptoms, therefore early detection and proper management are essential.
The University Health Network Osteoporosis Program (a joint program of University Health Network and Mount Sinai Hospital) is committed to providing excellent care for individuals with osteoporosis as well as up-to-date information on the prevention and treatment of the disease.
Our qualified, multidisciplinary staff of doctors, nurses, kinesiologists, dieticians and technologists is here to serve you and will be happy to address any issues or concerns you may have.
World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. 1994.
We see a broad spectrum of individuals at the Osteoporosis Program. As osteoporosis is most prevalent in postmenopausal women, we do screen and see many women over the age of 50. However, we also see other groups who may be at higher risk for developing the disease: individuals with hormonal imbalances (for example hyperparathyroidism, gonadal insufficiency, etc.), those who have undergone transplantation, individuals with long term steroid use, children with thalassemia, as well as individuals with eating disorders (this list is by no means exclusive).
* Please note that both the bone density lab and the clinic operate on a referral basis. Currently, the Ontario Health plan covers routine bone density testing for women over the age of 50 years (at low risk) once every two years. Please consult with your family physician for a referral.
The mission of the Osteoporosis Program is three-fold:
To educate individuals about the risk factors associated with osteoporosis, thereby encouraging appropriate preventive strategies.
To assist individuals diagnosed with osteoporosis in the satisfactory management of the disease, in hopes of improving bone mineral density, reducing fracture risk, and improving quality of life.
To be a leader among research teams investigating osteoporosis prevention and treatment.